Sutro Biopharma Inc Luvelta Investor Webcast Transcript
Good day and thank you for standing by, and welcome to the Sutro Biopharma Luvelta Forum webcast and conference call. (Operator Instructions) Again, please be advised that today's conference is being recorded. I would now like to hand the conference over to our first speaker today, Bill Newell, Chief Executive Officer of Sutro Biopharma. Please go ahead.
Thank you, Jonathan, and welcome to everybody who is joining us for today's Luvelta Forum. We decided to call this event a forum because for the first time, we will be presenting a comprehensive overview of the clinical and preclinical data in both solid tumors and hematologic malignancies that illustrates the broad therapeutic potential of our lead molecule, luveltamab tazevibulin or as we call it, luvelta.
Today, for the first time, we'll be presenting aggregated response data from approximately 100 treated ovarian cancer patients. We will also be presenting constant durability data for an aggregated 43 ovarian cancer patients,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
